GCF and serum myeloperoxidase and matrix metalloproteinase-13 levels in renal transplant patients
Makaleler > Tam Makale · 2010
Yazarlar: Gülnur EMİNGİL, Beral AFACAN, Taina Tervahartiala, Hüseyin TÖZ, FATMA GÜL ATİLLA, Timo Sorsa
Archives of Oral Biology, SCI Expanded İndekslerine Giren Dergi, Uluslararası, Wos, 2010, cilt 55, ss 719-727
DOI: 10.1016/j.archoralbio.2010.06.011
Özet
Aim: The rationale of this study was to address whether local or systemic changes reflect proteolytic (matrix metalloproteinase-13) or oxidative (myeloperoxidase) stress in renal transplant patients receiving cyclosporine-A (CsA) and having gingival overgrowth (GO), in patients receiving CsA therapy and having no GO and patients receiving tacrolimus therapy.